Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.

Konstantinopoulos, Panagiotis A

Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer. [electronic resource] - Gynecologic oncology Jun 2014 - 599-606 p. digital

Publication Type: Journal Article

1095-6859

10.1016/j.ygyno.2014.03.007 doi


Animals
Antineoplastic Agents--pharmacology
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
DNA Damage--drug effects
DNA, Neoplasm--drug effects
Down-Regulation
Drug Resistance, Neoplasm
Drug Synergism
Female
Histone Deacetylase Inhibitors--pharmacology
Humans
Hydroxamic Acids--pharmacology
Mice
Mice, Nude
Neoplasms, Glandular and Epithelial--genetics
Ovarian Neoplasms--genetics
Phthalazines--pharmacology
Piperazines--pharmacology
Recombinational DNA Repair--drug effects
Tissue Array Analysis
Vorinostat
Xenograft Model Antitumor Assays